Caris Life Sciences (CAI) executive Power gave up 9,771 shares at $15.25 to cover taxes or an exercise price
Insider transactions reported
Luke Thomas Power (executive at Caris Life Sciences Inc., CAI) reported that they gave up 9,771 shares at $15.25 to cover taxes or an exercise price on May 15, 2026. After these transactions the filing shows 153,771 shares held directly.
- Reporting person
- Power Luke Thomas
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 15, 2026 | Shares withheld for taxes or exercise price (F) | Common Stock1 | -9,771 | $15.25 | $149K | 153,771 direct |
Holdings before and after
- Common Stock: 163,542 to 153,771 direct
Footnotes from the filing
- 1. Shares withheld for the payment of taxes on the vesting and settlement of RSUs.
Transaction codes in this filing
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Power report in this CAI Form 4?
Luke Thomas Power (executive at Caris Life Sciences Inc., CAI) reported that they gave up 9,771 shares at $15.25 to cover taxes or an exercise price on May 15, 2026. After these transactions the filing shows 153,771 shares held directly.
How many CAI shares does Power hold after this filing?
The filing shows 153,771 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code F mean on an SEC Form 4?
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
Historical context for CAI
Across the 26 sessions after earlier CAI headlines, the stock closed higher 16 times and lower 10 times, with a median move of 3.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
Earlier insider filings at CAI
- May 18, 2026Officer Brille Brian J covered exercise/tax liability with 13,987 shares, decreasing direct ownership by 6% to 230,303 units (SEC Form 4)
- May 18, 2026President Spetzler David Baxley covered exercise/tax liability with 13,856 shares, decreasing direct ownership by 3% to 530,083 units (SEC Form 4)
- May 18, 2026Officer Halbert David D covered exercise/tax liability with 40,712 shares, decreasing direct ownership by 2% to 2,574,533 units (SEC Form 4)
- May 12, 2026Director Vacirca Jeff L bought $501,426 worth of shares (31,050 units at $16.15), increasing direct ownership by 167% to 49,671 units (SEC Form 4)
- Mar 10, 2026President Spetzler David Baxley was granted 83,162 shares, increasing direct ownership by 18% to 543,939 units (SEC Form 4)
Keep researching CAI
- CAI insider tradesEvery buy and sale reported by Caris Life Sciences Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- CAI earnings historyPast Caris Life Sciences Inc. earnings releases, newest first.
- CAI financial statementsRevenue, profit, cash flow and balance sheet from Caris Life Sciences Inc.'s SEC filings.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical Specialities
- Listed since
- 2025
Follow CAI and get a push notification the moment its next story breaks.